Delivery of drugs to the eye remains a significant challenge for drug formulation scientists. While topical eye drops are the most convenient type of formulation for delivery to the eye, they are generally restricted to delivery to the anterior segment of the eye and are poorly suited for delivery to the posterior segment of the eye. Targeted delivery to the posterior aspect of the eye (vitreous humor or retina) is impeded by a number of ocular barriers, and drug delivery to the posterior of the eye has been identified as a key unmet need in ophthalmology.
The theme of this program aims to develop novel methods for delivering drugs to the eye, and to develop technologies that allow drugs to penetrate the surface of the eye.
Principle Investigators: